Navigation Links
Rapamycin Optimized in 100 Liter Fermentor Using BioCommand Control Strategys

lly to a BioFlo 6000 Mobile Pilot Plant fermentor equipped with an ML-6100 touch-screen controller and 100 L working volurne vessel, (all equipment manufactured by New Brunswick Scientific, Edison, NJ). NBS' proprietary AFS-BioCommand software was used to control a multi-loop cascade strategy, wherein each of four process parameters were altered in sequence so as to maintain the desired D.O. level. Capable of managing up to eight fermentors, bioreactors, or ancillary instruments, this software automates the tedious and error-prone jobs of logging data, computing real and derived process values, and altering setpoints on the basis of time or metabolic events. In this study, AFS-BioCommand was programmed to maintain a D.O. level of 30% of air saturation by automatically increasing agitation rates from 200 to 450 rpm, then vessel pressure from 0.35 to 0.75 bar, aeration rate from 0.5 to 1 VVM and simultaneously shifting temperature from 28C to 25C, when D.O. fell below its setpoint. Based on optimization studies conducted on the bench level, pH was maintained between 6.2 and 6.8. A deadband was easily configured by using the local controller for the low setpoint and the supervisory control software for the high setpoint.


Discussion
Utilizing the multi-loop cascade strategy provided several benefits. First and foremost, D.O. was able to be maintained at optimal rates for production of rapamycin, a feat unable to be accomplished using a single loop control strategy ( see figure ). Agitation rates could also be significantly reduced, to minimize shear forces and enable higher yields of both cells and secondary metabolites.

Temperature was also lowered from that optimal for culture growth to the optimal range for rapamycin production. The lower temperature had the side benefit of slowing cell growth, thereby decreasing oxygen demands, which h
'"/>

Source:


Page: All 1 2 3

Related biology technology :

1. Optimized Imaging of Protein Gels Stained with Coomassie Brilliant Blue Dye
2. Eagle Eye Optical Filter Optimized for Imaging Silver-Stained Gels
3. Optimized Dengue RT-PCR
4. P. pastoris Fermentation using a BioFlo 110 Benchtop Fermentor
5. E. coli Fermentation Using a BioFlo 110 Bench-Top Fermentor
6. An Easy-to-Use Research Fermentor/Bioreactor
7. Fundamentals of Fermentation: Techniques For Benchtop Fermentors
8. Low Abundance cDNA Cloned Using Stratagenes Human Universal cDNA Library
9. Oil-Free PCR Using the Hot Top Assembly
10. Functional Cloning Using ViraPort Retroviral cDNA Expression Libraries
11. Signal Transduction Reporting Systems Using Cis-Acting Enhancer Elements

Post Your Comments:
(Date:11/6/2009)..., Nov. 6 BioSpecifics Te...ical company developing first-in-class collagenase...ults for the third quarter ended September 30, 200...ber of this year, the FDA,s Arthritis Advisory Com... the approval of XIAFLEX(TM) for the treatment of ...
(Date:11/6/2009)...stria, November 6 EUCODIS Bioscien...ng, and marketing enzymes for the,chemical industr...rch,agreement with Bio Sidus, the leading biopharm... agreement gives EUCODIS Bioscience exclusive acce...o Sidus, proprietary collection of,psychrophilic b...
(Date:11/6/2009)...6 /PRNewswire-FirstCall/ - Oncolytics Biotech Inc....any") today announced updated results from a Phase...ith sarcomas metastatic to the lung in a poster pr...cology Society Meeting held in Miami Beach, Florid...on, entitled "A Phase II Study of Intravenous REOL...
(Date:11/5/2009)...-- Gone hybrid . . . , Fuel economy ratings fo...ed at the www.fueleconomy.gov web site, which Oa...s for the U.S. Department of Energy and the U.S. E... vehicles on the best fuel economy list are hybrid...48 highway). "This list proves that hybrids have g...
Breaking Biology Technology:Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 2Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 3Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 4Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 5Reissue with Tables: BioSpecifics Technologies Corp. Reports Third Quarter 2009 Financial Results 6EUCODIS Bioscience to Explore Novel Enzymatic Activities in Antarctic Bacteria Library From Bio Sidus 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 2Oncolytics Biotech(R) Inc. Collaborators Present Positive Phase II Sarcoma Trial Results at CTOS Annual Meeting 3November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 2November 2009 story tips from the US Department of Energy's Oak Ridge National Laboratory 3
...iences Inc. today announced the development of a u...g from tissue hydration to the passivation of medi...is a series of patent-pending polymers that allow ... angle," says Andrew Loxley, PS, Director of New T...ed the system to develop an ocular formulation for...
...chnology today announced,that the company has obta...utilize Merck Eprova,s proprietary chiral lipid DO...ts in development based on the Versamune(TM),techn...oride shows enhanced,adjuvant activity compared to...enantiomerically pure DOTAP Chloride manufactured ...
...ork Sciences, Inc. (GNS) today announced that it h...Executive Officer of Stromedix, Inc. and former Ex... to its Board of Directors. , , Dr. Gilman has ...dix since June 2006. He was previously Executive ... Biogen in 1999 as Director of Molecular Biology a...
Other Biology Technology:Particle Sciences Completes Development of First Product Incorporating its Unique Surface Modification System 2PDS Biotechnology Corporation Finalizes Commercial Licensing Agreement with Merck Eprova AG to Utilize Merck Eprova's Enantiomers of DOTAP Chloride in Immunotherapies 2Gene Network Sciences Announces Michael Gilman as Board Member 2
(Date:11/4/2009)...ass., Oct. 20 Aware, Inc...d technology and biometrics software, today report...September 30, 2009. ,, Michael Tzannes, Aware...rlier today, we announced an agreement to sell our...a new fabless semiconductor company being spun out...
(Date:11/4/2009)..., Oct. 26 BIO-key Intern... in finger-based biometric identification software...s at the AABB TXPO conference being held at the Ne...9. BIO-key will provide hands-on product demonstra...ology in booth #424. Also, at 5 PM on Monday, Octo...
(Date:11/4/2009)...Calif., Nov. 4 GenVault Corporatio...y, M.D., Ph.D., has joined its Board of Directors....f the Salk Institute, is an acclaimed physician-sc...he Salk Institute, Dr. Brody served as president o... the National Academy of Engineering and the Insti...
Breaking Biology News(10 mins):Aware, Inc. Reports Third Quarter 2009 Financial Results 2Aware, Inc. Reports Third Quarter 2009 Financial Results 3Aware, Inc. Reports Third Quarter 2009 Financial Results 4Aware, Inc. Reports Third Quarter 2009 Financial Results 5Aware, Inc. Reports Third Quarter 2009 Financial Results 6Aware, Inc. Reports Third Quarter 2009 Financial Results 7BIO-key(R) International Exhibiting at AABB TXPO 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 2Dr. William Brody, President of the Salk Institute for Biological Studies, Appointed to GenVault's Board of Directors 3Susies Big Adventure Explores Plastic Surgery In Saudi Arabia 53959 1Beetroot Juice May Boost Stamina 53957 1Beetroot Juice May Boost Stamina 53957 2School Closures May Not Be Necessary When Swine Flu Strikes 53955 1School Closures May Not Be Necessary When Swine Flu Strikes 53955 2School Closures May Not Be Necessary When Swine Flu Strikes 53955 3School Closures May Not Be Necessary When Swine Flu Strikes 53955 4
..., Mass. (Oct. 20, 2008) -- Two teams of scientists...echnology (HST) at Brigham and Women,s Hospital ha...elivery system that is biocompatible, efficient at...ese structures can deliver clinically approved dru...rs for the drug or generating toxic components, a ...
...chers are on the verge of unleashing the power of ... therapies, as decades of research begins to bear ... best kept secrets, but is now attracting fast gro...rmaceutical industry in the quest for novel drugs ...lly overcoming limitations and side effects of cur...
...thers purposely expose their offspring to their ow...use it is widely accepted that exposure to materna...ative impacts on offspring following birth. To exa...pen, evolutionary physiologists Oliver Love and To... maternally-derived stress hormone corticosterone ...
Other Biology News:European researchers harness unique properties of boron to develop new drugs and diagnostics 2European researchers harness unique properties of boron to develop new drugs and diagnostics 3Exposing chicks to maternal stress leads to long-term reproductive success 2
Rabbit Anti-CRIPT Polyclonal Antibody, Unconjugated from Proteintech Group, Inc.
...quadrupole 1200L sets the new standard for value i...ng the latest technologies and providing tailored ... needs. The Atmospheric Pressure Ionization (API)...r provide superior selectivity and sensitivity for...
Goat Anti-Human Legumain Polyclonal Antibodies, from R&D Systems
Rat Anti-Mouse Endoglin Monoclonal Antibody, Fluorescein Conjugated, Clone 209701 from R&D Systems
Biology Products: